Remington G - Search Results

1

Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicity.

Shah P, Plitman E, Iwata Y, Kim J, Nakajima S, Chan N, Brown EE, Caravaggio F, Torres E, Hahn M, Chakravarty MM, Remington G, Gerretsen P, Graff-Guerrero A. Shah P, et al. Among authors: remington g. J Psychiatr Res. 2020 May;124:151-158. doi: 10.1016/j.jpsychires.2020.02.032. Epub 2020 Mar 5. J Psychiatr Res. 2020. PMID: 32169688

2

Antipsychotic dosing patterns for schizophrenia in three treatment settings.

Remington G, Shammi CM, Sethna R, Lawrence R. Remington G, et al. Psychiatr Serv. 2001 Jan;52(1):96-8. doi: 10.1176/appi.ps.52.1.96. Psychiatr Serv. 2001. PMID: 11141536

3

Augmentation strategies in clozapine-resistant schizophrenia.

Remington G, Saha A, Chong SA, Shammi C. Remington G, et al. CNS Drugs. 2005;19(10):843-72. doi: 10.2165/00023210-200519100-00004. CNS Drugs. 2005. PMID: 16185094 Review.

4

Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.

Novak G, Gallo A, Zai CC, Meltzer HY, Lieberman JA, Potkin SG, Voineskos AN, Remington G, Kennedy JL, Levesque D, Le Foll B. Novak G, et al. Among authors: remington g. Psychiatr Genet. 2010 Feb;20(1):39-43. doi: 10.1097/YPG.0b013e3283351221. Psychiatr Genet. 2010. PMID: 20010315

5

Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

Hahn MK, Cohn T, Remington G. Hahn MK, et al. Among authors: remington g. Ann Pharmacother. 2010 Jul-Aug;44(7-8):1349-50; author reply 1350-1. doi: 10.1345/aph.1M550a. Epub 2010 Jun 29. Ann Pharmacother. 2010. PMID: 20587740 No abstract available.

6

Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects.

Hahn MK, Remington G, Bois D, Cohn T. Hahn MK, et al. Among authors: remington g. J Clin Psychopharmacol. 2010 Dec;30(6):706-10. doi: 10.1097/jcp.0b013e3181fab67d. J Clin Psychopharmacol. 2010. PMID: 21105286 Clinical Trial.

7

Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment.

Remington G, Agid O, Foussias G. Remington G, et al. Expert Rev Neurother. 2011 Apr;11(4):589-607. doi: 10.1586/ern.10.191. Expert Rev Neurother. 2011. PMID: 21469931 Review.

8

Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model.

Hahn M, Chintoh A, Giacca A, Xu L, Lam L, Mann S, Fletcher P, Guenette M, Cohn T, Wolever T, Arenovich T, Remington G. Hahn M, et al. Among authors: remington g. Schizophr Res. 2011 Sep;131(1-3):90-5. doi: 10.1016/j.schres.2011.06.004. Epub 2011 Jun 22. Schizophr Res. 2011. PMID: 21696923

9

Exploring the neural correlates of delusions of reference.

Menon M, Schmitz TW, Anderson AK, Graff A, Korostil M, Mamo D, Gerretsen P, Addington J, Remington G, Kapur S. Menon M, et al. Among authors: remington g. Biol Psychiatry. 2011 Dec 15;70(12):1127-33. doi: 10.1016/j.biopsych.2011.05.037. Epub 2011 Aug 10. Biol Psychiatry. 2011. PMID: 21831358

10

Modeling chronic olanzapine exposure using osmotic minipumps: pharmacological limitations.

Remington G, Mann S, McCormick P, Nobrega JN, Hahn M, Natesan S. Remington G, et al. Pharmacol Biochem Behav. 2011 Nov;100(1):86-9. doi: 10.1016/j.pbb.2011.07.019. Epub 2011 Aug 3. Pharmacol Biochem Behav. 2011. PMID: 21839766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

530 results

Search Page